Quarterly report pursuant to Section 13 or 15(d)

Schedule of Segments (Tables)

v2.4.1.9
Schedule of Segments (Tables)
3 Months Ended
Mar. 31, 2015
Schedule of Segments (Tables)  
Schedule of Segment Reporting Information, by Segment

The Company also has certain small cancer related legacy investments and an $117,000 investment in note receivable from a non-affiliated party that is included in Corporate below.  

 

 

 

Cannabis and Medical Marijuana Segment

 

Legacy Investment

 

Corporate and Eliminations

 

Consolidated

Three months ended March 2015

 

 

 

 

 

 

 

 

Net sales

$

-

$

573 850

$

-

$

573,850

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

-

 

55 462

 

(245,316)

 

(183,317)

 

 

 

 

 

 

 

 

 

Total assets

 

1,626,740

 

1,114,834

 

1,140,954

 

3,882,528

 

 

 

 

 

 

 

 

 

Interest expense

 

-

 

4,774

 

(774)

 

4,000

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

-

 

6,810

 

683

 

7,493

 

 

 

 

 

 

 

 

 

Three months ended March 2014

 

 

 

 

 

 

 

 

Net sales

$

-

$

490,808

$

-

$

490,808

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

(21,551)

 

68,035

 

(136,953)

 

(90,469)

 

 

 

 

 

 

 

 

 

Total assets

 

1,600,927

 

1,122,564

 

1,270,899

 

3,994,390

 

 

 

 

 

 

 

 

 

Interest expense

 

-

 

4,093

 

397

 

4,490

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

-

 

6,091

 

3,369

 

9,460